Completed NA INTERVENTIONAL NCT00854516

Open Label Clinical Study to Assess the Clinical Safety of a New Compression Device in Subjects With Peripheral Arterial Vascular Disease

Open Label Clinical Study to Assess the Clinical Safety of a New Compression Procedure in Subjects With Peripheral Arterial Vascular Disease

Sponsor: 3M

Conditions Peripheral Arterial Vascular Disease

Interventions A new treatment approach is to have an effective working pressure combined with a low resting pressure.

Updated 6 times since 2017 Last updated: Sep 30, 2024 Started: Feb 28, 2009 Primary completion: Oct 31, 2009 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00854516, this NA trial focuses on Peripheral Arterial Vascular Disease and remains completed. Sponsored by 3M, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Nov 2024 — Present [monthly]

Completed NA
Sep 2024 — Nov 2024 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

3M
Solventum US LLC

Data source: Solventum US LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Greifswald, Germany